- Home
- VRAX vs AMZE Comparison
VRAX vs AMZE Comparison
Compare VRAX & AMZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- AMZE
- Stock Information
- Founded
- VRAX 2013
- AMZE 2019
- Country
- VRAX United Kingdom
- AMZE United States
- Employees
- VRAX N/A
- AMZE N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- AMZE Beverages (Production/Distribution)
- Sector
- VRAX Health Care
- AMZE Consumer Staples
- Exchange
- VRAX Nasdaq
- AMZE Nasdaq
- Market Cap
- VRAX 4.7M
- AMZE 5.2M
- IPO Year
- VRAX 2022
- AMZE 2021
- Fundamental
- Price
- VRAX $0.81
- AMZE $10.00
- Analyst Decision
- VRAX Strong Buy
- AMZE
- Analyst Count
- VRAX 1
- AMZE 0
- Target Price
- VRAX $3.00
- AMZE N/A
- AVG Volume (30 Days)
- VRAX 37.2K
- AMZE 71.2K
- Earning Date
- VRAX 02-05-2025
- AMZE 08-13-2025
- Dividend Yield
- VRAX N/A
- AMZE N/A
- EPS Growth
- VRAX N/A
- AMZE N/A
- EPS
- VRAX N/A
- AMZE N/A
- Revenue
- VRAX $84,872.00
- AMZE $254,711.00
- Revenue This Year
- VRAX $5,169.18
- AMZE N/A
- Revenue Next Year
- VRAX $66.97
- AMZE N/A
- P/E Ratio
- VRAX N/A
- AMZE N/A
- Revenue Growth
- VRAX 7.03
- AMZE N/A
- 52 Week Low
- VRAX $0.75
- AMZE $5.78
- 52 Week High
- VRAX $9.00
- AMZE $28.72
- Technical
- Relative Strength Index (RSI)
- VRAX 31.75
- AMZE N/A
- Support Level
- VRAX $0.75
- AMZE N/A
- Resistance Level
- VRAX $0.85
- AMZE N/A
- Average True Range (ATR)
- VRAX 0.07
- AMZE 0.00
- MACD
- VRAX -0.01
- AMZE 0.00
- Stochastic Oscillator
- VRAX 6.57
- AMZE 0.00
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About AMZE Amaze Holdings Inc. Common Stock
Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.